News
US health officials recommend reclassifying marijuana to a low risk drug
VI CONSORTIUM
FREDERIKSTED, St Croix, USVI- In a significant policy shift, US health authorities are advocating for the reclassification of marijuana as a Schedule III drug, according to a letter dated August 29, 2023, from the Department of Health and Human Services (HHS) to the Drug Enforcement Agency (DEA) (via Bloomberg). The move could potentially expand the cannabis market and has been based on a Food and Drug Administration (FDA) review.